After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Fate Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Fate Therapeutics Inc is $101.03M. A total of 0.97 million shares were traded on the day, compared to an average of 2.35M shares.
In the most recent transaction, Wolchko J Scott bought 113,178 shares of FATE for 0.93 per share on Mar 06 ’25. In a previous transaction on Jan 10 ’25, Bressi Jerome Charles sold 5,980 shares at 1.55 per share. FATE shares that the insider owns now total 270,203.
Among the insiders who sold shares, TAHL CINDY disposed of 5,654 shares on Jan 10 ’25 at a per-share price of $1.55. This resulted in the insider holding 336,707 shares of FATE after the transaction. In another insider transaction, Valamehr Bahram sold 8,705 shares at $1.54 per share on Jan 10 ’25. Company shares held by the President and CEO now total 349,364.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, FATE has a high of $7.65 and a low of $0.84.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. FATE’s latest balance sheet shows that the firm has $615.91M in Cash & Short Term Investments as of fiscal 2021. There were $114.82M in debt and $81.28M in liabilities at the time. Its Book Value Per Share was $2.80, while its Total Shareholder’s Equity was $678.84M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FATE is Buy with a score of 3.71.
